An audit-ready life sciences translation program rests on four controls: version control linking each translation to its approved source; an audit trail naming who translated, reviewed and approved each deliverable; terminology governance enforcing consistency across markets; and quality gates by content criticality. If any of these is informal, it's a finding waiting to happen.
What's at stake isn't only the inspection itself. Translation findings trigger remediation cost, delay submissions and can block market access on the products under review. This checklist helps Regulatory Operations, Document Control and Localization teams verify each control before an inspection window opens, not during one.
What Inspectors Look for in Translated Documentation
Regulatory inspectors don't evaluate translation quality in isolation. They look at the documentation system around translation: can the organization demonstrate controlled, traceable and reproducible language processes
Documentation and Standard Operating Procedure (SOP) failures rank among the most common findings in FDA inspections. A retrospective analysis of CDER warning letters issued from 2010 to 2020 (PMC, 2022) found that misbranding and poor documentation practices recur as primary citation categories. For multilingual programs, the most common findings on translation fall into three buckets:
-
Version control failures. A translated document that doesn't match the current approved source version, or where the version history is incomplete.
-
Missing review records. No documented evidence of who approved the translation, when, and against which quality standard.
-
Terminology inconsistencies. The same clinical, regulatory or safety term appearing in multiple forms across documents, markets or time periods.
Each of these is preventable. Each requires process design, not just linguistic expertise. The next section translates these findings into the four operational pillars that close the gaps.
The Four Pillars of an Audit-Ready Translation Program
1. Version control. Every translated document must be linked to a specific, approved source version. When the source is updated, the translation update must be triggered, tracked and documented. Not managed informally.
2. Audit trail. Translation and review activity must be recorded: who performed the translation, which quality check was applied, who approved the final output, and when. This applies to both AI-assisted and human-reviewed deliverables. ISO 17100 for human translation services and ISO 18587 for post-editing both require documented competence and traceability of each step.
3. Terminology governance. A managed term base covering approved clinical, regulatory, safety and product terminology, applied consistently across documents, markets and translators. Deviation from approved terms must be flagged and resolved, not left to individual judgment.
4. Quality gates by content criticality. Not all documents require the same level of review. High-criticality content (submissions, Instructions for Use (IFUs), labeling, safety narratives) requires mandatory human review with documented approval. Lower-criticality content may follow a lighter path, but the path must be defined and consistent.
Pre-Audit Checklist
Use this checklist to assess your translation program before an inspection. Gaps identified here are actionable. Address them before the audit window opens.
Version Control
- All translated documents are linked to a specific approved source version
- Version history is complete and retrievable, with no informal updates or undocumented revisions
- Outdated translations are archived and clearly marked as superseded, not in active circulation
- Change management process is documented: when a source changes, who triggers the translation update and within what timeline
Audit Trail and Documentation
-
Translation and review activity is logged: translator identity, date, review method, approver
-
For AI-assisted content: quality score, correction log and human review outcome are recorded
-
Approval records are retrievable by document, version and market
- Documentation is stored in a system that supports inspection access. Not in email threads or shared drives
Terminology governance
-
An approved term base exists and is actively maintained for each relevant language and market
-
Translation tools enforce approved terminology. Deviations are flagged automatically, not caught manually
-
Term base is version-controlled: updates are tracked, old terms archived with effective dates
-
Terminology is harmonized across document types: IFUs, SOPs, submissions, safety narratives, labeling.
Quality Gates and Escalation
- Content criticality tiers are defined: High-impact documents follow mandatory human review
- Quality criteria for each tier are documented and applied consistently. Not decided per project
- Escalation path is defined: what triggers human review, who performs it, what qualifies that person
- Quality records are retained with the translation file, not separately managed
Where Programs Typically Fail and What Fixes the Gap
The findings above almost always trace back to one of four operational gaps. Each has a defined fix.
Informal version management. Translation files tracked in spreadsheets or email chains can't produce a defensible audit trail. Fix: a structured workflow with versioned records and automated source-update triggers, not a manual workaround.
Terminology drift across markets. When local teams manage translations independently, the same term appears in different forms across markets. Fix: a centralized, enforced term base with active governance, not a glossary document sitting in a folder. For clinical content with cross-market consistency requirements, this is a non-negotiable baseline.
AI translation without documented controls. Using AI translation tools without a recorded quality process is an audit risk. Fix: quality scoring, correction log and human review decisions documented at the segment level. The tool isn't sufficient evidence. The process around it is what inspectors verify. Data handling, security and access controls sit in the same documentation scope.
Missing human review records for high-criticality content. For submissions, labeling, IFUs and safety narratives, inspectors expect to see who reviewed the translation and on what basis. Fix: a named, qualified reviewer with documented criteria, recorded with the translation file.
Key Takeaways
-
Audit readiness in translation is a process question, not a quality question. Inspectors verify traceability, not fluency.
-
Version control, audit trail, terminology governance and documented quality gates are the four non-negotiable pillars.
-
AI translation is acceptable in regulated environments when the process around it is controlled and documented.
-
The most common findings involve informal version management, terminology drift and missing human review records for high-criticality content.
-
Address these gaps before the inspection window opens. Reconstructing documentation under time pressure is high risk and expensive.
.jpg)
%20(1).jpg)
